{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T20:24:48Z","timestamp":1795033488605,"version":"4.10.2"},"reference-count":33,"publisher":"Ferrata Storti Foundation (Haematologica)","issue":"5","license":[{"start":{"date-parts":[[2023,10,19]],"date-time":"2023-10-19T00:00:00Z","timestamp":1697673600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["haematol"],"abstract":"<jats:p>T-cell acute lymphoblastic leukemia (T-ALL) is an aggressive malignancy derived from thymic T-cell precursors. Approximately 40-60% of T-ALL cases exhibit aberrant overexpression of the TAL1 oncogenic transcription factor. Here, we provide a comprehensive view of the TAL1-induced transcriptional program in human T-ALL cells using a rapid protein degradation system coupled with integrative approaches. Our study demonstrates that TAL1 targets can be classified into several groups, each of which exhibits unique gene expression kinetics, chromatin features, and regulatory mechanisms. Group A genes are highly dependent on TAL1, many of which are not expressed in normal T cells or TAL1-negative T-ALL cells, representing an oncogenic TAL1 signature. The TAL1 complex predominantly activates group A genes. TAL1\u2019s effect is not replaceable with its regulatory partners GATA3 or RUNX1. In contrast, group B genes, many of which are generally expressed across different T-ALL subgroups, exhibit densely-connected chromatin-chromatin interactions and demonstrate the collaborative roles played by TAL1 with other transcription factors. Interestingly, TAL1 cooperates with NOTCH1 to regulate gene expression in TAL1-positive T-ALL cells, whereas it potentially antagonizes the NOTCH1-MYC pathway and leads to lethality in TAL1-negative\/ TLX3-positive cells, demonstrating the context-dependent roles of TAL1.<\/jats:p>","DOI":"10.3324\/haematol.2023.283450","type":"journal-article","created":{"date-parts":[[2023,10,19]],"date-time":"2023-10-19T03:37:24Z","timestamp":1697686644000},"page":"1359-1372","source":"Crossref","is-referenced-by-count":6,"title":["Regulatory mechanisms and context-dependent roles of TAL1 in T-cell acute lymphoblastic leukemia"],"prefix":"10.3324","volume":"109","author":[{"given":"Jolynn Zu Lin","family":"Ong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tze King","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi Hao","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takaomi","family":"Sanda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1856","published-online":{"date-parts":[[2023,10,19]]},"reference":[{"key":"60251","doi-asserted-by":"crossref","unstructured":"Porcher C, Swat W, Rockwell K, Fujiwara Y, Alt FW, Orkin SH. The T cell leukemia oncoprotein SCL\/tal-1 is essential for development of all hematopoietic lineages. Cell. 1996; 86(1):47-57.","DOI":"10.1016\/S0092-8674(00)80076-8"},{"key":"60252","doi-asserted-by":"crossref","unstructured":"Shivdasani RA, Mayer EL, Orkin SH. Absence of blood formation in mice lacking the T-cell leukaemia oncoprotein tal-1\/SCL. Nature. 1995; 373(6513):432-434.","DOI":"10.1038\/373432a0"},{"key":"60253","doi-asserted-by":"crossref","unstructured":"Souroullas GP, Salmon JM, Sablitzky F, Curtis DJ, Goodell MA. Adult hematopoietic stem and progenitor cells require either Lyl1 or Scl for survival. Cell Stem Cell. 2009; 4(2):180-186.","DOI":"10.1016\/j.stem.2009.01.001"},{"key":"60254","doi-asserted-by":"crossref","unstructured":"Yui MA, Rothenberg EV. Developmental gene networks: a triathlon on the course to T cell identity. Nat Rev Immunol. 2014; 14(8):529-545.","DOI":"10.1038\/nri3702"},{"key":"60255","doi-asserted-by":"crossref","unstructured":"Hosokawa H, Rothenberg EV. How transcription factors drive choice of the T cell fate. Nat Rev Immunol. 2021; 21(3):162-176.","DOI":"10.1038\/s41577-020-00426-6"},{"key":"60256","doi-asserted-by":"crossref","unstructured":"Aifantis I, Raetz E, Buonamici S. Molecular pathogenesis of T-cell leukaemia and lymphoma. Nat Rev Immunol. 2008; 8(5):380-390.","DOI":"10.1038\/nri2304"},{"key":"60257","doi-asserted-by":"crossref","unstructured":"Belver L, Ferrando A. The genetics and mechanisms of T cell acute lymphoblastic leukaemia. Nat Rev Cancer. 2016; 16(8):494-507.","DOI":"10.1038\/nrc.2016.63"},{"key":"60258","doi-asserted-by":"crossref","unstructured":"O\u2019Neil J, Shank J, Cusson N, Murre C, Kelliher M. TAL1\/SCL induces leukemia by inhibiting the transcriptional activity of E47\/HEB. Cancer Cell. 2004; 5(6):587-596.","DOI":"10.1016\/j.ccr.2004.05.023"},{"key":"60259","doi-asserted-by":"crossref","unstructured":"Draheim KM, Hermance N, Yang Y, Arous E, Calvo J, Kelliher MA. A DNA-binding mutant of TAL1 cooperates with LMO2 to cause T cell leukemia in mice. Oncogene. 2011; 30(10):1252-1260.","DOI":"10.1038\/onc.2010.495"},{"key":"60260","doi-asserted-by":"crossref","unstructured":"Zhang C, Amanda S, Wang C. Oncorequisite role of an aldehyde dehydrogenase in the pathogenesis of T-cell acute lymphoblastic leukemia. Haematologica. 2021; 106(6):1545-1558.","DOI":"10.3324\/haematol.2019.245639"},{"key":"60261","doi-asserted-by":"crossref","unstructured":"Mansour MR, Abraham BJ, Anders L. An oncogenic super-enhancer formed through somatic mutation of a noncoding intergenic element. Science. 2014; 346(6215):1373-1377.","DOI":"10.1126\/science.1259037"},{"key":"60262","doi-asserted-by":"crossref","unstructured":"Sanda T, Lawton LN, Barrasa MI. Core transcriptional regulatory circuit controlled by the TAL1 complex in human T cell acute lymphoblastic leukemia. Cancer Cell. 2012; 22(2):209-221.","DOI":"10.1016\/j.ccr.2012.06.007"},{"key":"60263","doi-asserted-by":"crossref","unstructured":"Weng AP, Ferrando AA, Lee W. Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia. Science. 2004; 306(5694):269-271.","DOI":"10.1126\/science.1102160"},{"key":"60264","doi-asserted-by":"crossref","unstructured":"Herranz D, Ambesi-Impiombato A, Palomero T. A NOTCH1-driven MYC enhancer promotes T cell development, transformation and acute lymphoblastic leukemia. Nat Med. 2014; 20(10):1130-1137.","DOI":"10.1038\/nm.3665"},{"key":"60265","doi-asserted-by":"crossref","unstructured":"O\u2019Neil J, Calvo J, McKenna K. Activating Notch1 mutations in mouse models of T-ALL. Blood. 2006; 107(2):781-785.","DOI":"10.1182\/blood-2005-06-2553"},{"key":"60266","doi-asserted-by":"crossref","unstructured":"Liau WS, Tan SH Ngoc PCT. Aberrant activation of the GIMAP enhancer by oncogenic transcription factors in T-cell acute lymphoblastic leukemia. Leukemia. 2017; 31(8):1798-1807.","DOI":"10.1038\/leu.2016.392"},{"key":"60267","doi-asserted-by":"crossref","unstructured":"Liu Y, Easton J, Shao Y. The genomic landscape of pediatric and young adult T-lineage acute lymphoblastic leukemia. Nat Genet. 2017; 49(8):1211-1218.","DOI":"10.1038\/ng.3909"},{"key":"60268","doi-asserted-by":"crossref","unstructured":"Ferrando AA, Neuberg DS, Staunton J. Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia. Cancer Cell. 2002; 1(1):75-87.","DOI":"10.1016\/S1535-6108(02)00018-1"},{"key":"60269","doi-asserted-by":"crossref","unstructured":"Yeoh EJ, Ross ME, Shurtleff SA. Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling. Cancer Cell. 2002; 1(2):133-143.","DOI":"10.1016\/S1535-6108(02)00032-6"},{"key":"60270","doi-asserted-by":"crossref","unstructured":"Nabet B, Roberts JM, Buckley DL. The dTAG system for immediate and target-specific protein degradation. Nat Chem Biol. 2018; 14(5):431-441.","DOI":"10.1038\/s41589-018-0021-8"},{"key":"60271","doi-asserted-by":"crossref","unstructured":"Wong RWJ, Ngoc PCT, Leong WZ. Enhancer profiling identifies critical cancer genes and characterizes cell identity in adult T-cell leukemia. Blood. 2017; 130(21):2326-2338.","DOI":"10.1182\/blood-2017-06-792184"},{"key":"60272","doi-asserted-by":"crossref","unstructured":"Krijger PH, Geeven G, Bianchi V, Hilvering CR, de Laat W. 4C-seq from beginning to end: a detailed protocol for sample preparation and data analysis. Methods. 2020; 170:17-32.","DOI":"10.1016\/j.ymeth.2019.07.014"},{"key":"60273","doi-asserted-by":"crossref","unstructured":"Buenrostro JD, Wu B, Chang HY, Greenleaf WJ. ATAC-seq: a method for assaying chromatin accessibility genome-wide. Curr Protoc Mol Biol. 2015; 109(1):21.","DOI":"10.1002\/0471142727.mb2129s109"},{"key":"60274","doi-asserted-by":"crossref","unstructured":"Mansour MR, Sanda T, Lawton LN. The TAL1 complex targets the FBXW7 tumor suppressor by activating miR-223 in human T cell acute lymphoblastic leukemia. J Exp Med. 2013; 210(8):1545-1557.","DOI":"10.1084\/jem.20122516"},{"key":"60275","doi-asserted-by":"crossref","unstructured":"Kusy S, Gerby B, Goardon N. NKX3. 1 is a direct TAL1 target gene that mediates proliferation of TAL1-expressing human T cell acute lymphoblastic leukemia. J Exp Med. 2010; 207(10):2141-2156.","DOI":"10.1084\/jem.20100745"},{"key":"60276","doi-asserted-by":"crossref","unstructured":"Leong WZ, Tan SH, Ngoc PCT. ARID5B as a critical downstream target of the TAL1 complex that activates the oncogenic transcriptional program and promotes T-cell leukemogenesis. Gen Dev. 2017; 31(23-24):2343-2360.","DOI":"10.1101\/gad.302646.117"},{"key":"60277","doi-asserted-by":"crossref","unstructured":"Murre C. Helix-loop-helix proteins and lymphocyte development. Nat Immunol. 2005; 6(11):1079-1086.","DOI":"10.1038\/ni1260"},{"key":"60278","doi-asserted-by":"crossref","unstructured":"Kee BL. E and ID proteins branch out. Nat Rev Immunol. 2009; 9(3):175-184.","DOI":"10.1038\/nri2507"},{"key":"60279","doi-asserted-by":"crossref","unstructured":"Seita J, Sahoo D, Rossi DJ. Gene Expression Commons: an open platform for absolute gene expression profiling. PLoS One. 2012; 7(7):e40321.","DOI":"10.1371\/journal.pone.0040321"},{"key":"60280","doi-asserted-by":"crossref","unstructured":"Wang H, Zou J, Zhao B. Genome-wide analysis reveals conserved and divergent features of Notch1\/RBPJ binding in human and murine T-lymphoblastic leukemia cells. Proc Natl Acad Sci U S A. 2011; 108(36):14908-14913.","DOI":"10.1073\/pnas.1109023108"},{"key":"60281","doi-asserted-by":"crossref","unstructured":"Begley CG, Aplan PD, Davey MP. Chromosomal translocation in a human leukemic stem-cell line disrupts the T-cell antigen receptor delta-chain diversity region and results in a previously unreported fusion transcript. Proc Natl Acad Sci U S A. 1989; 86(6):2031-2035.","DOI":"10.1073\/pnas.86.6.2031"},{"key":"60282","doi-asserted-by":"crossref","unstructured":"Belver L, Yang AY, Albero R. GATA3-controlled nucleosome eviction drives MYC enhancer activity in T-cell development and leukemia. Cancer Discov. 2019; 9(12):1774-1791.","DOI":"10.1158\/2159-8290.CD-19-0471"},{"key":"60283","doi-asserted-by":"crossref","unstructured":"Corces MR, Buenrostro JD, Wu B. Lineage-specific and single-cell chromatin accessibility charts human hematopoiesis and leukemia evolution. Nat Genet. 2016; 48(10):1193-1203.","DOI":"10.1038\/ng.3646"}],"container-title":["Haematologica"],"original-title":[],"link":[{"URL":"https:\/\/haematologica.org\/article\/download\/haematol.2023.283450\/76176","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/haematologica.org\/article\/download\/haematol.2023.283450\/76930","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/haematologica.org\/article\/download\/11309\/76176","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T10:05:05Z","timestamp":1794045905000},"score":1,"resource":{"primary":{"URL":"https:\/\/haematologica.org\/article\/view\/haematol.2023.283450"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,19]]},"references-count":33,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2024,5,1]]}},"URL":"https:\/\/doi.org\/10.3324\/haematol.2023.283450","relation":{},"ISSN":["1592-8721","0390-6078"],"issn-type":[{"value":"1592-8721","type":"electronic"},{"value":"0390-6078","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10,19]]}}}